1 Min Read
Nov 29 (Reuters) - Neuronix Ltd
* Neuronix reports positive results in its multi-center alzheimer’s study and submits its therapy system for FDA clearance Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.